Generation and Characterization of Torudokimab (LY3375880): A Monoclonal Antibody That Neutralizes Interleukin-33Angela J. Okragly(Eli Lilly (United States)), Robert J. Benschop(Eli Lilly (United States))Journal of Inflammation ResearchAugust 1, 202110.2147/jir.s320287Cited by 16SaveCiteExport RISWatch citationsRelated PapersInterleukin-33 Contributes Toward Loss of Tolerance by Promoting B-Cell-Activating Factor of the Tumor-Necrosis-Factor Family (BAFF)-Dependent Autoantibody Production|Frontiers in Immunology|2018|21